XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Income/(Loss) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Net sales $ 674.1 $ 383.6 $ 1,507.3 $ 1,049.6
Cost of products sold 551.0 298.4 1,192.0 795.5
Gross profit 123.1 85.2 315.3 254.1
Selling expense 22.3 13.2 51.6 34.2
Research and development expense 7.7 5.7 18.3 14.9
General expense 105.2 41.4 203.5 126.7
Total nonmanufacturing expenses 135.2 60.3 273.4 175.8
Restructuring and impairment expense 1.8 1.9 17.4 5.9
Operating profit/(loss) (13.9) 23.0 24.5 72.4
Interest expense 23.8 15.3 58.7 31.3
Other income, net 2.4 3.7 15.2 0.8
Income/(loss) before income taxes and income from equity affiliates (35.3) 11.4 (19.0) 41.9
Income tax expense/(benefit) (11.5) 1.5 (4.8) 12.4
Income from equity affiliates, net of income taxes 1.3 2.3 5.1 6.1
Net income/(loss) $ (22.5) $ 12.2 $ (9.1) $ 35.6
Net income/(loss) per share:        
Basic (in dollars per share) $ (0.43) $ 0.38 $ (0.25) $ 1.13
Diluted (in dollars per share) $ (0.43) $ 0.38 $ (0.25) $ 1.12
Weighted average shares outstanding:        
Basic (in shares) 52,593,900 31,046,100 38,415,900 31,022,100
Diluted (in shares) 52,593,900 31,401,000 38,415,900 31,381,600